Brigatinib
Title | Journal |
---|---|
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. | Journal of medicinal chemistry 20160526 |
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. | Proceedings of the National Academy of Sciences of the United States of America 20110503 |